Pediatric Neurology
Volume 29, Issue 2 , Pages 151-156 , August 2003

Rasmussen syndrome and long-term response to thalidomide

  • Borivoj D Marjanovic, PhD

      Affiliations

    • Department of Neurology, Pediatric Clinic of Mother and Child Health Care Institute, Belgrade, Yugoslavia
    • Corresponding Author InformationCommunications should be addressed to: Dr. Marjanovic; Mother and Child Health Institute; 8 Radoja Dakica St; 11070, Belgrade, Yugoslavia.
  • ,
  • Ljubomir M Stojanov, PhD

      Affiliations

    • Department of Metabolic and Genetic Diseases, Pediatric Clinic of Mother and Child Health Care Institute, Belgrade, Yugoslavia
  • ,
  • Dragan S Zdravkovic, PhD

      Affiliations

    • Department of Endocrinology, Pediatric Clinic of Mother and Child Health Care Institute, Belgrade, Yugoslavia.
  • ,
  • Ruzica M Kravljanac, MD

      Affiliations

    • Department of Neurology, Pediatric Clinic of Mother and Child Health Care Institute, Belgrade, Yugoslavia
  • ,
  • Maja S Djordjevic, MD

      Affiliations

    • Department of Metabolic and Genetic Diseases, Pediatric Clinic of Mother and Child Health Care Institute, Belgrade, Yugoslavia

Received 19 September 2002 ,Accepted 25 February 2003.

References 

  1. Gordon N. Rasmussens’s encephalitis. Dev Med Child Neurol. 1997;39:133–136
  2. Rasmussen T, Olszweski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology. 1958;8:435–455
  3. Jay V, Becker LE, Otsubo H, et al.  Chronic encephalitis and epilepsy (Rasmussen encephalitis) (Detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridisation). Neurology. 1995;45:108–117
  4. Frassoni C, Spreafico R, Franceschetti S, et al.  Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitis. Neurology. 2001;57:324–327
  5. Wyllie E. Surgical treatment of epilepsy in children. Pediatr Neurol. 1998;19:179–188
  6. Chinchilla D, Dulac O, Robain O, et al.  Reappraisal of Rasmussen’s syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry. 1994;57:1325–1333
  7. Oguni H, Andermann F, Rasmussen TB. The natural history of the syndrome of chronic encephalitis and epilepsy (A study of the MNI series of forty-eight cases). In:  Andermann F editors. Chronic encephalitis and epilepsy (Rasmussen syndrome). Boston: Butterworth-Heinemann; 1991;p. 37–45
  8. Gosalkkal JA. Rasmussen syndrome of chronic focal encephalitis. Eur J Paediatr Neurol. 2002;6:67–72
  9. Vinters HV, Wang R, Wiley CA. Herpes viruses in chronic encephalitis associated with intractable childhood epilepsy. Hum Pathol. 1993;24:871–879
  10. Rogers SW, Andrewes PI, Gahring LC, et al.  Autoantibodies to glutamate receptors (GluR3) in Rasmussen’s encephalitis. Science. 1994;265:648–651
  11. Antozzi C, Granata T, Aurisano N, et al.  Long-term selective IgG immunoadsorption improves Rasmussen’s encephalitis. Neurology. 1998;51:302–305
  12. Li Y, Uccelli A, Laxer KD, et al.  Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen’s. J Immunol. 1997;158:1428–1437
  13. Wise MS, Rutledge SL, Kurniecky RI. Rasmussen syndrome and long-term response to gamma globulin. Pediatr Neurol. 1996;14:149–152
  14. Andrews PJ, Dichter MA, Berkovic SF, et al.  Plasmapheresis in Rassmusen’s encephalitis. Neurology. 1996;46:242–246
  15. Rasmussen T. Hemispherectomy for seizures revisited. J Can Sci Neurol. 1983;10:71–78
  16. Honovar M, Janota I, Polkey CE. Rasmussen’s encephalitis in surgery for epilepsy. Dev Med Child Neurol. 1992;34:3–14
  17. Ravenscroft A, Schoemen JF, Pretorious ML, et al.  Rasmussen’s encephalitis (Case presentation and discussion on the role of specific immune modulation). [abstract] Brain Dev. 1998;20:398
  18. Sato EI, Assis LSS, Lourenzi VP, et al.  Long-term thalidomide use in refractory cutaneus lesions of systemic lupus erythematosus. Rev Assoc Med Bras. 1998;44:288–293
  19. Yazici H, Yurdakul S, Hamuryudan V. Behcet’s syndrome. Curr Opin Rheumatol. 1999;11:53–57
  20. Ghate JV, Jorizzo JL. Bechet’s disease and complex aphtosis. J Am Acad Dermatol. 1999;40:1–18
  21. Gottlieb S. Thalidomide produces benefits in some patients with tumours. BMJ. 2001;323:360
  22. Kling J. Redeeming thalidomide (Clinical trials for this notorious drug suggest uses against cancer and autoimmune diseases). Modern Drug Discovery. 2000;3:35; , 36, 39
  23. Gupt A, Cohen BH, Ruggieri P, et al.  Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology. 2003;60:130–132
  24. Chandry V, Cornblath DR, Corse A, et al.  Thalidomide-induced neuropathy. Neurology. 2002;59:1872–1875

PII: S0887-8994(03)00216-9

doi: 10.1016/S0887-8994(03)00216-9

Pediatric Neurology
Volume 29, Issue 2 , Pages 151-156 , August 2003